• Skyline Isolations

Cannabinoids for Neuropathic Pain

Updated: Nov 28, 2018

ABSTRACT

Treatment options for neuropathic pain have limited efficacy and use is fraught with dose-limiting adverse effects. The endocannabinoid system has been elucidated over the last several years, demonstrating a significant interface with pain homeostasis. Exogenous cannabinoids have been demonstrated to be effective in a range of experimental neuropathic pain models, and there is mounting evidence for therapeutic use in human neuropathic pain conditions. This article reviews the history, pharmacologic development, clinical trials results, and the future potential of nonsmoked, orally bioavailable, nonpsychoactive cannabinoids in the management of neuropathic pain.

CLICK TO READ FULL STUDY

KEY WORDS: #CBD #Inflammation #Pain #Glycine #Receptors #Neuropathic #Chronic

SOURCE: U.S. National Library of Medicine - National Institutes of Health

AUTHORS: Fine PG, Rosenfeld MJ

ABOUT

CONTACT US

SHOP

  • Skyline Isolations Instagram
  • Skyline Isolations Facebook
  • Skyline Pinterest
  • Skyline Isolations LinkedIn
  • Skyline Isolations Twitter

© 2017 by Skyline Isolations LLC

DISCLAIMER: SKYLINE DOES NOT MAKE ANY CLAIMS, BUT DISCUSSES PUBLICLY AVAILABLE ANECDOTAL EVIDENCE, RESOURCES AND BOTH EDUCATIONAL AND MEDICAL JOURNALS.

Products may have o.1% of THC content or less.